/

Empresas

Ap

No verificado

Aptar Pharma

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaSaludSanidad

24 Comunicados de prensa

Ver todos los comunicados de prensa

12/11/2026

Aptar Pharma Expands Services Capabilities to Support Development of Inhaled and Nasal Drug Products Containing Controlled Substances

Fuente

Editor

1.00

0

27/10/2026

Aptar Pharma and Stevanato Group Collaborate to Help Accelerate Pre-Filled Syringe System Selection

Fuente

Editor

1.00

0

26/10/2026

Aptar Pharma Acquires Pulmotree, Expanding Growth Opportunities in Next-Generation Pulmonary Drug Delivery

Fuente

Editor

1.00

0

14/10/2026

Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers

Fuente

Editor

1.00

0

06/10/2026

Industria

Sanidad

Farmacéutica

Material médico sanitario

VIH, SIDA y enfermedades autoinmunes

Almacenamiento/Embalaje

Química

Biotecnología

Salud

Aptar Expands Pharma Operations in Mumbai, Reinforcing India as a Strategic Growth Market

Fuente

Editor

1.00

0

05/10/2026

Aptar Pharma Launches Premia™ Precision, a New Quality Standard for Demanding Injectable Therapies

Fuente

Editor

1.00

0

11/09/2026

Aptar Pharma Expands Preservative Free Technology Production in Latin America

Fuente

Editor

1.00

0

07/09/2026

Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis

Fuente

Editor

1.00

0

12/08/2026

Industria

Vídeo

Farmacéutica

Software

Material médico sanitario

Sanidad

Tecnología de la información

Asociaciones/Profesionales

Fitness

Técnica

Medicina - Varios

Biotecnología

Salud

Almacenamiento/Embalaje

Noble Secures New Patent for AI-Powered Sound Detection in Drug Delivery and Diagnostic Devices

Fuente

Editor

1.00

0

22/07/2026

Industria

Sanidad

Técnica

Farmacéutica

Material médico sanitario

Fitness

Medicina - Varios

Biotecnología

Software

Almacenamiento/Embalaje

Salud

Aptar Pharma Announces GMP Certification at Nanopharm, Strengthening Its Integrated Pharma Services Offering

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0